The current BMKDF market cap is 18.64M. The company's latest EPS is CAD -0.0203 and P/E is -10.34.
Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 0 | 263k | 0 | 44k | 153k |
Operating Income | -545k | -703k | -554k | -719k | -1.21M |
Net Income | -545k | -1.22M | -1.09M | -1.45M | -1.84M |
Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Assets | 34k | 637k | 952k | 1.47M | 732k |
Total Liabilities | 1.25M | 1.08M | 1.03M | 2.11M | 1.88M |
Total Equity | -1.22M | -439k | -80k | -636k | -1.15M |
Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Operating | -278k | -454k | -457k | -1.2M | -915k |
Investing | N/A | -1,000 | -3k | -59k | -5k |
Financing | 261k | 1.05M | 725k | 769k | 609k |
Market Cap | 18.64M |
Price to Earnings Ratio | -10.34 |
Price to Sales Ratio | 123.53 |
Price to Cash Ratio | 262.5 |
Price to Book Ratio | -16.61 |
Dividend Yield | - |
Shares Outstanding | 90.89M |
Average Volume (1 week) | 12.43k |
Average Volume (1 Month) | 8.89k |
52 Week Change | 2.55% |
52 Week High | 0.253062 |
52 Week Low | 0.143 |
Spread (Intraday) | 0.15 (60.95%) |
Company Name | Biomark Diagnostics Inc (PK) |
Address |
130 - 3851 shell rd richmond, british columbia V6X 2W2 |
Website | https://www.biomarkdiagnostics.com |
Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.